MCID: BRS032
MIFTS: 30

Breast Papillary Carcinoma

Categories: Cancer diseases

Aliases & Classifications for Breast Papillary Carcinoma

MalaCards integrated aliases for Breast Papillary Carcinoma:

Name: Breast Papillary Carcinoma 12 15
Solid Papillary Carcinoma of the Breast 12
Papillary Carcinoma of the Breast 12
Breast Solid Papillary Carcinoma 12
Papillary Carcinoma of Breast 12

Classifications:



External Ids:

Disease Ontology 12 DOID:5592
NCIt 49 C6870
UMLS 71 C1336027

Summaries for Breast Papillary Carcinoma

Disease Ontology : 12 A breast carcinoma that is characterized by the presence of arborescent fibrovascular stalks lined by epithelial cells, grossly forming a circumscribed mass.

MalaCards based summary : Breast Papillary Carcinoma, also known as solid papillary carcinoma of the breast, is related to bilateral breast cancer and mammary paget's disease. An important gene associated with Breast Papillary Carcinoma is SYP (Synaptophysin), and among its related pathways/superpathways is Signaling by ERBB4. Affiliated tissues include breast, lung and thyroid, and related phenotype is Decreased viability in esophageal squamous lineage.

Related Diseases for Breast Papillary Carcinoma

Diseases related to Breast Papillary Carcinoma via text searches within MalaCards or GeneCards Suite gene sharing:

(showing 278, show less)
# Related Disease Score Top Affiliating Genes
1 bilateral breast cancer 29.6 PGR ESR1 ERBB2
2 mammary paget's disease 29.6 PGR ESR1 ERBB2
3 signet ring cell adenocarcinoma 29.6 ERBB2 CHGA
4 papillary carcinoma 29.5 SYP PGR ESR1 ERBB2 CHGA
5 in situ carcinoma 29.2 PGR KRT5 ESR1 ERBB2
6 ductal carcinoma in situ 29.2 PGR KRT5 ESR1 ERBB2
7 apocrine adenocarcinoma 28.7 PGR KRT5 ESR1 ERBB2
8 cribriform carcinoma 28.7 PGR KRT5 ESR1 ERBB2
9 intraductal papilloma 28.7 PGR KRT5 ESR1 ERBB2
10 tubular adenocarcinoma 28.7 SYP PGR ESR1 ERBB2 CHGA
11 sweat gland cancer 28.3 SYP PGR KRT5 ESR1 ERBB2
12 intracystic papillary adenoma 28.1 PGR KRT5 ESR1 ERBB2 CHGA
13 lung meningioma 10.4 SYP PGR
14 glycogen-rich clear cell breast carcinoma 10.4 SYP PGR
15 mucinous adenofibroma 10.3 SYP ESR1
16 prostate stromal sarcoma 10.3 SYP PGR
17 bartholin's gland adenoid cystic carcinoma 10.3 PGR ESR1
18 chronic tympanitis 10.3 PGR ESR1
19 bartholin's gland adenoma 10.3 PGR ESR1
20 granulomatous endometritis 10.3 PGR ESR1
21 endometritis 10.3 PGR ESR1
22 bartholin's gland benign neoplasm 10.3 PGR ESR1
23 vestibular gland benign neoplasm 10.3 PGR ESR1
24 lung leiomyoma 10.3 PGR ESR1
25 vulvar syringoma 10.3 PGR ESR1
26 trigonitis 10.3 PGR ESR1
27 vagina leiomyosarcoma 10.3 PGR ESR1
28 adult type testicular granulosa cell tumor 10.3 PGR ESR1
29 ovarian seromucinous carcinoma 10.3 PGR ESR1
30 breast leiomyoma 10.3 PGR ESR1
31 intravenous leiomyomatosis 10.3 PGR ESR1
32 liver leiomyoma 10.3 PGR ESR1
33 mammographic density 10.3 PGR ESR1
34 vulvar leiomyoma 10.3 PGR ESR1
35 bizarre leiomyoma 10.3 PGR ESR1
36 chordoid glioma 10.3 SYP PGR
37 spinal cancer 10.3 SYP PGR
38 endosalpingiosis 10.3 PGR ESR1
39 progesterone resistance 10.3 PGR ESR1
40 cervical mucinous adenocarcinoma 10.3 PGR ESR1
41 adenomyoma 10.3 PGR ESR1
42 ureter small cell carcinoma 10.3 SYP CHGA
43 gender identity disorder 10.3 PGR ESR1
44 juvenile nasopharyngeal angiofibroma 10.3 PGR ESR1
45 primary hepatic neuroendocrine carcinoma 10.3 SYP CHGA
46 perivascular epithelioid cell tumor 10.3 SYP PGR
47 ovarian large-cell neuroendocrine carcinoma 10.3 SYP CHGA
48 pancreas lymphoma 10.3 SYP CHGA
49 small cell carcinoma of the bladder 10.3 SYP CHGA
50 vulvar benign neoplasm 10.3 PGR ESR1
51 acinar cell cystadenocarcinoma 10.3 SYP CHGA
52 vulvar eccrine porocarcinoma 10.3 SYP CHGA
53 urinary bladder small cell neuroendocrine carcinoma 10.3 SYP CHGA
54 laryngeal neuroendocrine tumor 10.3 SYP CHGA
55 gastrointestinal neuroendocrine benign tumor 10.3 SYP CHGA
56 appendix carcinoid tumor 10.3 SYP CHGA
57 auditory system cancer 10.3 SYP CHGA
58 mixed ductal-endocrine carcinoma 10.3 SYP CHGA
59 thymus small cell carcinoma 10.3 SYP CHGA
60 papillary thymic adenocarcinoma 10.3 SYP CHGA
61 cauda equina neoplasm 10.3 SYP CHGA
62 duodenal benign neoplasm 10.3 SYP CHGA
63 adult mesoblastic nephroma 10.3 PGR ESR1
64 ampulla of vater neoplasm 10.3 SYP CHGA
65 vaginal cancer 10.2 PGR ESR1
66 vaginal tubulovillous adenoma 10.2 SYP CHGA
67 vaginal adenoma 10.2 SYP CHGA
68 nodular ganglioneuroblastoma 10.2 SYP CHGA
69 ovarian endometrial cancer 10.2 PGR ESR1
70 esophageal adenoid cystic carcinoma 10.2 SYP CHGA
71 carotid body cancer 10.2 SYP CHGA
72 gastric small cell carcinoma 10.2 SYP CHGA
73 vaginal glandular tumor 10.2 PGR CHGA
74 gastric neuroendocrine neoplasm 10.2 SYP CHGA
75 estrogen excess 10.2 PGR ESR1
76 cervical neuroblastoma 10.2 SYP CHGA
77 subependymoma 10.2 SYP CHGA
78 pineocytoma 10.2 SYP CHGA
79 cervical large cell neuroendocrine carcinoma 10.2 SYP CHGA
80 pulmonary large cell neuroendocrine carcinoma 10.2 SYP CHGA
81 rare tumor 10.2
82 lung oat cell carcinoma 10.2 SYP CHGA
83 cutaneous ganglioneuroma 10.2 SYP CHGA
84 ganglioneuroma 10.2 SYP CHGA
85 endometrial small cell carcinoma 10.2 SYP CHGA
86 vaginal discharge 10.2 PGR ESR1
87 cervix small cell carcinoma 10.2 SYP CHGA
88 esophageal neuroendocrine tumor 10.2 SYP CHGA
89 pancreatic gastrinoma 10.2 SYP CHGA
90 sertoli-leydig cell tumor 10.2 SYP PGR
91 gastrointestinal neuroendocrine tumor 10.2 SYP CHGA
92 carcinoid tumors, intestinal 10.2 SYP CHGA
93 gallbladder small cell carcinoma 10.2 SYP CHGA
94 colon neuroendocrine neoplasm 10.2 SYP CHGA
95 carcinoid syndrome 10.2 SYP CHGA
96 binswanger's disease 10.2 SYP CHGA
97 chordoid meningioma 10.2 SYP CHGA
98 pancreatic acinar cell adenocarcinoma 10.2 SYP CHGA
99 olfactory neuroblastoma 10.2 SYP CHGA
100 endocervical carcinoma 10.2 PGR ESR1
101 extra-adrenal pheochromocytoma 10.2 SYP CHGA
102 small intestine benign neoplasm 10.2 SYP CHGA
103 pulmonary neuroendocrine tumor 10.2 SYP CHGA
104 prostate neuroendocrine neoplasm 10.2 SYP CHGA
105 glomangiomatosis 10.2 SYP CHGA
106 endometriosis of ovary 10.2 PGR ESR1
107 olfactory nerve neoplasm 10.2 SYP CHGA
108 cranial nerve malignant neoplasm 10.2 SYP CHGA
109 gangliocytoma 10.2 SYP CHGA
110 leydig cell tumor 10.2 SYP ESR1
111 endometrial disease 10.2 PGR ESR1
112 pelvic lipomatosis 10.2 SYP CHGA
113 cranial nerve neoplasm 10.2 SYP CHGA
114 sertoli cell tumor 10.2 SYP PGR
115 horseshoe kidney 10.2 SYP CHGA
116 pulmonary sclerosing hemangioma 10.2 SYP CHGA
117 microcystic adenoma 10.2 SYP CHGA
118 adrenal medulla cancer 10.2 SYP CHGA
119 prostatic hypertrophy 10.2 PGR ESR1
120 scirrhous adenocarcinoma 10.2 PGR ERBB2
121 autonomic nervous system benign neoplasm 10.2 SYP CHGA
122 lacrimal gland adenocarcinoma 10.2 SLC16A4 SLC16A3
123 peripheral nervous system benign neoplasm 10.2 SYP CHGA
124 pancreatoblastoma 10.2 SYP CHGA
125 pancreatic endocrine carcinoma 10.2 SYP CHGA
126 apocrine adenosis of breast 10.2 PGR ERBB2
127 lacrimal gland adenoid cystic carcinoma 10.2 SLC16A4 SLC16A3
128 cecal disease 10.1 SYP CHGA
129 breast adenoid cystic carcinoma 10.1 PGR ERBB2
130 pleomorphic xanthoastrocytoma 10.1 SYP CHGA
131 endocervical adenocarcinoma 10.1 PGR ESR1
132 linitis plastica 10.1 PGR ERBB2
133 basaloid squamous cell carcinoma 10.1 SYP CHGA
134 smooth muscle tumor 10.1 PGR ESR1
135 thyroid gland medullary carcinoma 10.1 SYP CHGA
136 central neurocytoma 10.1 SYP CHGA
137 peritoneal mesothelioma 10.1 PGR ESR1
138 primary peritoneal carcinoma 10.1 PGR ERBB2
139 gastric diffuse adenocarcinoma 10.1 PGR ERBB2
140 acinar cell carcinoma 10.1 SYP CHGA
141 subependymal giant cell astrocytoma 10.1 SYP CHGA
142 lung large cell carcinoma 10.1 SYP CHGA
143 vaginal endometrial stromal sarcoma 10.1 SYP PGR ESR1
144 vagina sarcoma 10.1 SYP PGR ESR1
145 lacrimal gland carcinoma 10.1 SLC16A4 SLC16A3
146 pancreatic cystadenoma 10.1 SYP CHGA
147 vulvar disease 10.1 PGR ERBB2
148 mature teratoma 10.1 SYP ERBB2
149 papillary adenoma 10.1 SYP KRT5
150 uterine benign neoplasm 10.1 PGR ESR1
151 reproductive organ benign neoplasm 10.0 PGR ESR1
152 cell type benign neoplasm 10.0 SYP PGR ESR1
153 adenocarcinoma 10.0
154 pulmonary blastoma 10.0 SYP CHGA
155 cloacogenic carcinoma 10.0 SYP KRT5
156 central nervous system benign neoplasm 10.0 SYP CHGA
157 adrenal cortical carcinoma 10.0 SYP CHGA
158 clear cell adenocarcinoma 10.0 PGR ESR1
159 pregnancy adenoma 10.0 PGR KRT5
160 external ear carcinoma 10.0 PGR KRT5
161 papillary squamous carcinoma 10.0 SYP KRT5
162 vaginal benign neoplasm 10.0 SYP PGR CHGA
163 clear cell meningioma 10.0 SYP PGR CHGA
164 sclerosing hemangioma 10.0 SYP PGR CHGA
165 hemangioma 10.0 SYP PGR CHGA
166 nasal cavity olfactory neuroblastoma 10.0 SYP KRT5
167 cystadenoma 10.0 SYP PGR CHGA
168 endobronchial lipoma 10.0 SYP KRT5
169 breast myoepithelial carcinoma 10.0 PGR KRT5
170 keratinizing squamous cell carcinoma 10.0 SYP KRT5
171 lymphoepithelioma-like thymic carcinoma 10.0 SYP KRT5
172 central epithelioid sarcoma 10.0 SYP KRT5
173 vulvar proximal-type epithelioid sarcoma 10.0 SYP KRT5
174 cutaneous adenocystic carcinoma 10.0 PGR KRT5
175 cystic basal cell carcinoma 10.0 SYP KRT5
176 uterus leiomyosarcoma 9.9 PGR KRT5
177 adenomyosis 9.9 PGR ESR1
178 teratoma 9.9 SYP ESR1 CHGA
179 adrenal cortical adenoma 9.9 SYP CHGA
180 pelvic organ prolapse 9.9 PGR ESR1
181 thyroid cancer, nonmedullary, 1 9.9
182 cholelithiasis 9.9
183 neuroendocrine carcinoma 9.9
184 thyroid gland papillary carcinoma 9.9
185 rare breast tumor 9.9
186 thyroid carcinoma 9.9
187 ovarian serous cystadenocarcinoma 9.9 SYP PGR ERBB2
188 glassy cell carcinoma of the cervix 9.9 PGR ESR1 ERBB2
189 breast juvenile papillomatosis 9.9 PGR ESR1 ERBB2
190 breast scirrhous carcinoma 9.9 PGR ESR1 ERBB2
191 oncocytic breast carcinoma 9.9 PGR ESR1 ERBB2
192 comedo carcinoma 9.9 PGR ESR1 ERBB2
193 progesterone-receptor negative breast cancer 9.9 PGR ESR1 ERBB2
194 breast sarcoma 9.9 PGR ESR1 ERBB2
195 progesterone-receptor positive breast cancer 9.9 PGR ESR1 ERBB2
196 microglandular adenosis 9.9 PGR ESR1 ERBB2
197 hypertrophy of breast 9.9 PGR ESR1 ERBB2
198 female reproductive endometrioid cancer 9.9 PGR ESR1 ERBB2
199 adenosarcoma 9.9 PGR ESR1 ERBB2
200 inflammatory breast carcinoma 9.9 PGR ESR1 ERBB2
201 uterine corpus cancer 9.9 PGR ESR1 ERBB2
202 amelogenesis imperfecta, type ig 9.9 PGR ESR1 ERBB2
203 amelogenesis imperfecta 9.9 PGR ESR1 ERBB2
204 estrogen-receptor negative breast cancer 9.9 PGR ESR1 ERBB2
205 breast fibroadenoma 9.9 PGR ESR1 ERBB2
206 breast cancer 9.9
207 breast cyst 9.9
208 squamous cell papilloma 9.9
209 papilloma 9.9
210 teeth hard tissue disease 9.9 PGR ESR1 ERBB2
211 fallopian tube carcinoma 9.9 PGR ESR1 ERBB2
212 mucinous adenocarcinoma 9.9 PGR ESR1 ERBB2
213 gynecomastia 9.9 PGR ESR1 ERBB2
214 female breast cancer 9.9 PGR ESR1 ERBB2
215 endometrial adenocarcinoma 9.9 PGR ESR1 ERBB2
216 sporadic breast cancer 9.9 PGR ESR1 ERBB2
217 estrogen-receptor positive breast cancer 9.9 PGR ESR1 ERBB2
218 ovary adenocarcinoma 9.9 PGR ESR1 ERBB2
219 malignant ovarian surface epithelial-stromal neoplasm 9.8 PGR ESR1 ERBB2
220 sweat gland neoplasm 9.8 KRT5 ERBB2
221 ovary epithelial cancer 9.8 PGR ESR1 ERBB2
222 clear cell basal cell carcinoma 9.8 KRT5 CHGA
223 uterine carcinosarcoma 9.8 PGR ESR1 ERBB2
224 breast cystic hypersecretory carcinoma 9.8 KRT5 ERBB2
225 granulosa cell tumor of the ovary 9.8 SYP ERBB2 CHGA
226 malignant pheochromocytoma 9.8 SYP ERBB2 CHGA
227 esophageal adenosquamous carcinoma 9.8 KRT5 ERBB2
228 eccrine papillary adenocarcinoma 9.8 SYP PGR KRT5
229 cardiovascular organ benign neoplasm 9.8 SYP CHGA
230 adenosquamous carcinoma 9.8 SYP PGR KRT5
231 thoracic cancer 9.7 PGR ESR1 ERBB2
232 paget disease, extramammary 9.7 KRT5 ERBB2
233 ovarian disease 9.7 PGR ESR1 ERBB2
234 peritoneum cancer 9.7 KRT5 ERBB2
235 sebaceous adenocarcinoma 9.7 KRT5 ERBB2
236 primary pigmented nodular adrenocortical disease 9.7 SYP PGR ESR1 CHGA
237 middle ear adenoma 9.7 SYP KRT5 CHGA
238 sensory organ benign neoplasm 9.7 SYP KRT5 CHGA
239 laryngeal small cell carcinoma 9.7 SYP KRT5 CHGA
240 lung clear cell carcinoma 9.7 SYP KRT5 CHGA
241 middle ear carcinoma 9.7 SYP KRT5 CHGA
242 mediastinal cancer 9.7 SYP KRT5 CHGA
243 respiratory system benign neoplasm 9.7 SYP KRT5 CHGA
244 gastrointestinal stromal tumor 9.6 SYP ERBB2 CHGA
245 adrenal gland disease 9.6 SYP CHGA
246 meningioma, familial 9.6 SYP PGR ESR1 ERBB2
247 wilms tumor 1 9.6 SYP PGR ESR1 ERBB2
248 vulva basal cell carcinoma 9.6 SYP KRT5 ERBB2
249 lipid-rich breast carcinoma 9.6 PGR KRT5 ERBB2
250 breast mucinous carcinoma 9.6 PGR KRT5 ERBB2
251 apocrine sweat gland neoplasm 9.6 PGR KRT5 ERBB2
252 adenoid cystic carcinoma 9.6 PGR KRT5 ERBB2
253 oropharynx cancer 9.6 PGR KRT5 ERBB2
254 ewing sarcoma 9.5 SYP ERBB2 CHGA
255 neuroblastoma 9.5 SYP ESR1 ERBB2 CHGA
256 mucoepidermoid carcinoma 9.4 KRT5 ERBB2 CHGA
257 breast metaplastic carcinoma 9.3 PGR KRT5 ESR1 ERBB2
258 lipid-rich carcinoma 9.3 PGR KRT5 ESR1 ERBB2
259 breast malignant phyllodes tumor 9.3 PGR KRT5 ESR1 ERBB2
260 breast osteosarcoma 9.3 PGR KRT5 ESR1 ERBB2
261 intraductal breast neoplasm 9.3 PGR KRT5 ESR1 ERBB2
262 sweat gland disease 9.3 PGR KRT5 ESR1 ERBB2
263 lobular neoplasia 9.3 PGR KRT5 ESR1 ERBB2
264 thoracic benign neoplasm 9.3 PGR KRT5 ESR1 ERBB2
265 breast benign neoplasm 9.3 PGR KRT5 ESR1 ERBB2
266 tonsil cancer 9.3 PGR KRT5 ESR1 ERBB2
267 luminal breast carcinoma 9.3 PGR KRT5 ESR1 ERBB2
268 pre-malignant neoplasm 9.3 PGR KRT5 ESR1 ERBB2
269 breast carcinoma in situ 9.2 PGR KRT5 ESR1 ERBB2
270 breast disease 9.2 PGR KRT5 ESR1 ERBB2
271 breast neuroendocrine neoplasm 9.2 SYP PGR ESR1 ERBB2 CHGA
272 large cell neuroendocrine carcinoma 9.2 SYP PGR ESR1 ERBB2 CHGA
273 breast adenocarcinoma 9.2 SYP PGR ESR1 ERBB2 CHGA
274 large cell carcinoma 9.2 SYP KRT5 ERBB2 CHGA
275 spindle cell carcinoma 9.1 SYP PGR KRT5 ESR1 CHGA
276 mixed cell type cancer 9.0 SYP PGR KRT5 ESR1 ERBB2
277 breast ductal carcinoma 9.0 SYP PGR KRT5 ESR1 ERBB2
278 suppression of tumorigenicity 12 8.9 SYP KRT5 ESR1 ERBB2 CHGA

Graphical network of the top 20 diseases related to Breast Papillary Carcinoma:



Diseases related to Breast Papillary Carcinoma

Symptoms & Phenotypes for Breast Papillary Carcinoma

GenomeRNAi Phenotypes related to Breast Papillary Carcinoma according to GeneCards Suite gene sharing:

26 (showing 1, show less)
# Description GenomeRNAi Source Accession Score Top Affiliating Genes
1 Decreased viability in esophageal squamous lineage GR00235-A 9.1 CHGA ERBB2 ESR1 PGR SLC16A3 SLC16A4

Drugs & Therapeutics for Breast Papillary Carcinoma

Search Clinical Trials , NIH Clinical Center for Breast Papillary Carcinoma

Genetic Tests for Breast Papillary Carcinoma

Anatomical Context for Breast Papillary Carcinoma

MalaCards organs/tissues related to Breast Papillary Carcinoma:

40
Breast, Lung, Thyroid, Ovary, Prostate, Cervix, Thymus

Publications for Breast Papillary Carcinoma

Articles related to Breast Papillary Carcinoma:

(showing 30, show less)
# Title Authors PMID Year
1
Fine-needle aspiration cytology of solid papillary carcinoma of the breast. 61
31513348 2020
2
Solid Papillary Carcinoma of the Breast: Magnetic Resonance Mammography, Digital Mammography, and Ultrasound Findings. 61
29613993 2018
3
Solid papillary carcinoma of the breast with an associated Cytokeratin 7- negative Paget's disease of the nipple. Report of a first case. 61
29265587 2018
4
Endocrine mucin-producing sweat gland carcinoma: A study of 11 cases with molecular analysis. 61
29943394 2018
5
A pilot evaluation of magnetic resonance imaging characteristics seen with solid papillary carcinomas of the breast in 4 patients. 61
28784112 2017
6
Endocrine Mucin-Producing Sweat Gland Carcinoma, a Histological Challenge. 61
28299221 2017
7
Clinicopathologic Characteristics of Solid Papillary Carcinoma of the Breast. 61
27438988 2016
8
Metastatic gastrinoma in the breast mimicking primary solid papillary carcinoma. 61
27342908 2016
9
Solid papillary carcinoma of the breast: A special entity needs to be distinguished from conventional invasive carcinoma avoiding over-treatment. 61
27017244 2016
10
[Endocrine mucin-producing sweat gland carcinoma. three case reports with a brief review of the literature]. 61
25085634 2014
11
Expression of glycolysis-related proteins in solid papillary carcinoma of the breast according to basement membrane status. 61
24719122 2014
12
Invasive (solid) Papillary Carcinoma of the Breast: A Report of Two Cases. 61
23905125 2013
13
Endocrine mucin-producing sweat gland carcinoma: report of two cases of an under-recognized malignant neoplasm and review of the literature. 61
22892473 2013
14
Synchronous bilateral solid papillary carcinomas of the breast. 61
23844308 2013
15
Solid papillary carcinoma of the breast: a pathologically and clinically distinct breast tumor. 61
23020734 2012
16
A case of endocrine mucin-producing sweat gland carcinoma. 61
22524664 2012
17
Solid papillary carcinoma of the breast with neuroendocrine features in a pregnant woman: a case report. 61
21876491 2011
18
Solid papillary carcinoma of the breast: imprint cytological and histological findings. 61
20340006 2010
19
Loss of myoepithelium is variable in solid papillary carcinoma of the breast. 61
17927587 2007
20
Cytological study of 20 cases of solid-papillary carcinoma of the breast. 61
17580353 2007
21
Solid-papillary carcinoma of the breast: clinicopathological study of 20 cases. 61
17587241 2007
22
Clinicopathologic analysis of solid papillary carcinoma of the breast and associated invasive carcinomas. 61
16625097 2006
23
Fine needle aspiration cytology of solid papillary carcinoma of the breast. A report of four cases. 61
12685198 2003
24
Solid papillary carcinoma of the breast: report of two cases. 61
11407528 2001
25
Fine needle aspiration cytology of a solid papillary carcinoma of the breast. A case report with immunohistochemical studies. 61
9622695 1998
26
Endocrine mucin-producing sweat gland carcinoma: a cutaneous neoplasm analogous to solid papillary carcinoma of breast. 61
9414195 1997
27
Solid papillary carcinoma of breast: an ultrastructural study. 61
9090026 1997
28
Solid papillary carcinoma of the breast. 61
9042298 1997
29
Solid papillary carcinoma of the breast. A form of intraductal carcinoma with endocrine differentiation frequently associated with mucinous carcinoma. 61
7573685 1995
30
[Five simultaneous neoplasms]. 61
2825093 1987

Variations for Breast Papillary Carcinoma

Cosmic variations for Breast Papillary Carcinoma:

9 (showing 24, show less)
# Cosmic Mut ID Gene Symbol COSMIC Disease Classification
(Primary site, Site subtype, Primary histology, Histology subtype)
Mutation CDS Mutation AA GRCh38 Location Conf
1 COSM87897745 TP53 breast,NS,carcinoma,papillary c.524G>A p.R175H 17:7675088-7675088 21
2 COSM87132245 PIK3CA breast,NS,carcinoma,papillary c.3140A>G p.H1047R 3:179234297-179234297 21
3 COSM97107336 NRAS breast,NS,carcinoma,papillary c.183A>C p.Q61H 1:114713907-114713907 21
4 COSM88889220 APC breast,NS,carcinoma,papillary c.3571C>T p.Q1191* 5:112839165-112839165 21
5 COSM112253124 breast,NS,carcinoma,papillary c.524G>A p.R175H 17:7675088-7675088 21
6 COSM105619860 breast,NS,carcinoma,papillary c.524G>A p.R175H 17:7675088-7675088 21
7 COSM122733880 breast,NS,carcinoma,papillary c.128G>A p.R43H 17:7675088-7675088 21
8 COSM148932633 breast,NS,carcinoma,papillary c.*220A>G p.? 3:179234297-179234297 21
9 COSM106052917 breast,NS,carcinoma,papillary c.524G>A p.R175H 17:7675088-7675088 21
10 COSM143156608 breast,NS,carcinoma,papillary c.47G>A p.R16H 17:7675088-7675088 21
11 COSM143943565 breast,NS,carcinoma,papillary c.47G>A p.R16H 17:7675088-7675088 21
12 COSM122404515 breast,NS,carcinoma,papillary c.3571C>T p.Q1191* 5:112839165-112839165 21
13 COSM144650780 breast,NS,carcinoma,papillary c.407G>A p.R136H 17:7675088-7675088 21
14 COSM121875575 breast,NS,carcinoma,papillary c.128G>A p.R43H 17:7675088-7675088 21
15 COSM145017326 breast,NS,carcinoma,papillary c.407G>A p.R136H 17:7675088-7675088 21
16 COSM144013113 breast,NS,carcinoma,papillary c.491G>A p.R164H 17:7675088-7675088 21
17 COSM142837093 breast,NS,carcinoma,papillary c.524G>A p.R175H 17:7675088-7675088 21
18 COSM122271291 breast,NS,carcinoma,papillary c.128G>A p.R43H 17:7675088-7675088 21
19 COSM144086975 breast,NS,carcinoma,papillary c.47G>A p.R16H 17:7675088-7675088 21
20 COSM142559914 breast,NS,carcinoma,papillary c.407G>A p.R136H 17:7675088-7675088 21
21 COSM111758247 breast,NS,carcinoma,papillary c.524G>A p.R175H 17:7675088-7675088 21
22 COSM143370595 breast,NS,carcinoma,papillary c.407G>A p.R136H 17:7675088-7675088 21
23 COSM144309944 breast,NS,carcinoma,papillary c.407G>A p.R136H 17:7675088-7675088 21
24 COSM93183307 breast,NS,carcinoma,papillary c.524G>A p.R175H 17:7675088-7675088 21

Expression for Breast Papillary Carcinoma

Search GEO for disease gene expression data for Breast Papillary Carcinoma.

Pathways for Breast Papillary Carcinoma

Pathways related to Breast Papillary Carcinoma according to GeneCards Suite gene sharing:

(showing 1, show less)
# Super pathways Score Top Affiliating Genes
1
Show member pathways
10.83 PGR ESR1 ERBB2

GO Terms for Breast Papillary Carcinoma

Cellular components related to Breast Papillary Carcinoma according to GeneCards Suite gene sharing:

(showing 1, show less)
# Name GO ID Score Top Affiliating Genes
1 membrane GO:0016020 9.23 SYP SLC16A4 SLC16A3 PGR KRT5 ESR1

Biological processes related to Breast Papillary Carcinoma according to GeneCards Suite gene sharing:

(showing 1, show less)
# Name GO ID Score Top Affiliating Genes
1 monocarboxylic acid transport GO:0015718 8.62 SLC16A4 SLC16A3

Molecular functions related to Breast Papillary Carcinoma according to GeneCards Suite gene sharing:

(showing 3, show less)
# Name GO ID Score Top Affiliating Genes
1 nuclear receptor activity GO:0004879 9.16 PGR ESR1
2 steroid binding GO:0005496 8.96 PGR ESR1
3 monocarboxylic acid transmembrane transporter activity GO:0008028 8.62 SLC16A4 SLC16A3

Sources for Breast Papillary Carcinoma

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
17 EFO
18 ExPASy
19 FMA
28 GO
29 GTR
30 HMDB
31 HPO
32 ICD10
33 ICD10 via Orphanet
34 ICD9CM
35 IUPHAR
36 KEGG
37 LifeMap
39 LOVD
41 MedGen
43 MeSH
44 MESH via Orphanet
45 MGI
48 NCI
49 NCIt
50 NDF-RT
53 NINDS
54 Novoseek
56 OMIM
57 OMIM via Orphanet
61 PubMed
63 QIAGEN
68 SNOMED-CT via HPO
69 TGDB
70 Tocris
71 UMLS
72 UMLS via Orphanet
Content
Loading form....